Abstract:Key PointsThe development of the next generation of nanoparticle therapeutics — based on polymeric nanoparticles that combine the pre-eminent features of traditional delivery vectors such as liposomes and polymer-drug conjugates, but offer new flexibility to overcome some of the key barriers in the field — is gaining momentum.To achieve intracellular drug delivery, strategies for overcoming various biological barriers — from the system level, to the organ level and to the cellular level — are needed. For intravenously injected engineered nanoparticles, the avoidance of multiple organ-level clearance mechanisms, such as those operating in the spleen and in the liver, must be compensated for if the carrier is to reach its intended destination. Ultimately, the effectiveness of any engineered nanoparticle will depend on the efficiency of the carrier to deliver its cargo to the intracellular site of action, which in many cases requires organelle-specific targeting.The size, the surface characteristics and the shape of a nanoparticle have a key role in its biodistribution in vivo. The effects of size have been studied extensively with spherically shaped particles and some general trends have been noted. Particle size is also known to influence the mechanism of cellular internalization. However, current findings indicate that particle shape is just as important, if not more so, than size in controlling key aspects of both biodistribution and nanoparticle internalization.Achieving tailored activated release of therapeutic cargo still represents a key barrier in the field of engineered nanoparticles. The predominant strategies so far incorporate materials that are enzymatically degradable, pH sensitive or reductively labile, which facilitate bond breaking between the drug and the carrier, or destabilization of the carrier on reaching the intended site of action.

Custom protein nanoparticles for targeted drug delivery

Coating nanoparticles with cell membranes for targeted drug delivery

Protein Nanoparticles Directed Cancer Imaging and Therapy

Targeted protein delivery based on stimuli-triggered nanomedicine

Modular Construction of Multifunctional Bioresponsive Cell-Targeted Nanoparticles for Gene Delivery.

Nanocarriers for intracellular delivery of proteins in biomedical applications: strategies and recent advances

Protein Nanoparticles: Promising Platforms for Drug Delivery Applications

Protein-Based Nanoparticles as Drug Delivery Systems

A Novel Intracellular Protein Delivery Platform Based on Single-Protein Nanocapsules

Nano‐ and Micro‐Platforms in Therapeutic Proteins Delivery for Cancer Therapy: Materials and Strategies

Synthesis of protein nanoparticles for drug delivery

Strategies in the design of nanoparticles for therapeutic applications

Targeted protein degradation via cellular trafficking of nanoparticles

A modular encapsulation system for precision delivery of proteins, nucleic acids and therapeutics

Nanomaterial Strategies for Delivery of Therapeutic Cargoes

Enhanced Prostate-specific Membrane Antigen Targeting by Precision Control of DNA Scaffolded Nanoparticle Ligand Presentation

Bioengineering Strategies for Protein-Based Nanoparticles

Paracellular Delivery of Protein Drugs with Smart EnteroPatho Nanoparticles

Computational design of non-porous pH-responsive antibody nanoparticles

Peptide‐conjugated Nanoparticle Platforms for Targeted Delivery, Imaging, and Biosensing Applications

Advancements in Programmable Lipid Nanoparticles: Exploring the Four-Domain Model for Targeted Drug Delivery